| Author |
Title |
JournalName |
Year D |
| Click on Column Headers to Re-Sort The Current List |
| Roberts AS, Alexander F |
Report on Clinical Evaluation of SKF #5 (Amphedoxamine) [MDA] |
[Memo, 1957 Aug 21] |
1957 |
| Naranjo C, Shulgin AT, Sa... |
Evaluation of 3,4-methylenedioxyamphetamine MDA as an adjunct to psych... |
Med Pharmacol Exp In... |
1967 |
| Richards RN |
Experience with MDA |
Can Med Assoc J |
1972 |
| Turek IS, Soskin RA, Kurl... |
Methylenedioxyamphetamine (MDA) Subjective Effects |
Journal of Psychedel... |
1974 |
| Nichols DE, Ilhan M, Long... |
Comparison of Cardiovascular, Hyperthermic, and Toxic Effects of Para-... |
Arch Int de Pharmaco... |
1975 |
| Yensen R |
The Use of 3, 4 Methylenedioxyamphetamine (MDA) as an Adjunct to Brief... |
Dissertation UC Irvi... |
1975 |
| Lopatka JE, Brewerton CN,... |
The protective effects of methysergide, 6-hydroxydopamine and other ag... |
Res Commun Chem Path... |
1976 |
| Yensen R, Di Leo FB, Rhea... |
MDA-assisted psychotherapy with neurotic outpatients: a pilot study |
J Nerv Ment Dis |
1976 |
| Marquardt GM, DiStefano V... |
Pharmacological effects of (+/-)-, (S)-, and (R)-MDA |
Psychopharmacology o... |
1976 |
| Shulgin, A. |
Profiles of Psychedelic Drugs: MMDA |
Journal of Psychoact... |
1976 |
| Shannon HE |
MDA and DOM: Substituted Amphetamines that do not Produce Amphetamine-... |
Psychopharmacology |
1980 |
| Davis WM, Borne RF |
Pharmacologic investigation of compounds related to 3,4-methylenedioxy... |
Subst Alcohol Action... |
1984 |
| Glennon RA, Young R |
MDA: An Agent That Produces Stimulus Effects Similar to Those of 3,4-D... |
European J Pharmacol |
1984 |
| Brady JF, Di Stefano EW, ... |
Spectral and inhibitory interactions of (+/-)-3,4-methylenedioxyamphet... |
Life Sci |
1986 |
| Climko RP, Roehrich H, Sw... |
Ecstacy: a review of MDMA and MDA |
Int J Psychiatry Med |
1986 |
| Johnson MP, Hoffman AJ, N... |
Effects of the enantiomers of MDA, MDMA and related analogues on [3H]s... |
Eur J Pharmacol |
1986 |
| Stone DM, Stahl DC, Hanso... |
The effects of 3,4-methylenedioxymethamphetamine (MDMA) and 3,4-methyl... |
Eur J Pharmacol |
1986 |
| Davis WM, Catravas JD, Wa... |
Effects of an i.v. lethal dose of 3,4-methylenedioxyamphetamine (MDA) ... |
Gen Pharmacol |
1986 |
| Davis WM, Hatoum HT, Wate... |
Toxicity of MDA (3,4-methylenedioxyamphetamine) considered for relevan... |
Alcohol Drug Res |
1987 |
| Rosecrans JA, Glennon RA |
The effect of MDA and MDMA ('Ecstasy') isomers in combination with pir... |
Pharmacol Biochem Be... |
1987 |
| Stone DM, Johnson M, Hans... |
A comparison of the neurotoxic potential of methylenedioxyamphetamine ... |
Eur J Pharmacol |
1987 |
| Glennon RA, Yousif M, Pat... |
Stimulus properties of 1-(3,4-methylenedioxyphenyl)-2-aminopropane (MD... |
Pharmacol Biochem Be... |
1988 |
| O'Hearn E, Battaglia G, D... |
Methylenedioxyamphetamine (MDA) and methylenedioxymethamphetamine (MDM... |
J Neurosci |
1988 |
| Ramos JM Jr, Fitzgerald R... |
MDMA and MDA cross reactivity observed with Abbott TDx amphetamine/met... |
Clin Chem |
1988 |
| De Souza EB, Battaglia G |
Effects of MDMA and MDA on brain serotonin neurons: evidence from neur... |
NIDA Res Monogr |
1989 |
| Fitzgerald RL, Blanke RV,... |
Stereochemistry of the metabolism of MDMA to MDA |
Life Sci |
1989 |
| Glennon RA, Misenheimer B... |
Stimulus effects of N-monoethyl-1-(3,4-methylenedioxyphenyl)-2-aminopr... |
Pharmacol Biochem Be... |
1989 |
| Nader MA, Hoffmann SM, Ba... |
Behavioral effects of (+-) 3,4-methylenedioxyamphetamine (MDA) and (+-... |
Psychopharmacology (... |
1989 |
| Nichols DE, Oberlender R,... |
Studies of dioxole ring substituted 3,4-methylenedioxyamphetamine (MDA... |
Pharmacol Biochem Be... |
1989 |
| Glennon RA, Misenheimer B... |
Stimulus effects of N-monoethyl-1-(3,4-methylenedioxyphenyl)-2-aminopr... |
Pharmacol Biochem Be... |
1989 |
| Finnegan KT, Skratt JJ, I... |
The N-methyl-D-aspartate (NMDA) receptor antagonist, dextrorphan, prev... |
Neurosci Lett |
1990 |
| Nichols DE, Brewster WK, ... |
Nonneurotoxic tetralin and indan analogues of 3,4-(methylenedioxy)amph... |
J Med Chem |
1990 |
| McKenna DJ, Guan XM, Shul... |
3,4-Methylenedioxyamphetamine (MDA) analogues exhibit differential eff... |
Pharmacol Biochem Be... |
1991 |
| McCann UD, Ricaurte GA |
Major metabolites of (+/-)3,4-methylenedioxyamphetamine (MDA) do not m... |
Brain Res |
1991 |
| Olney JW, Labruyere J, Wa... |
NMDA antagonist neurotoxicity: mechanism and prevention |
Science |
1991 |
| Broadbent JJ, Appel JB J,... |
Discriminative stimulus effects of the optical isomers of 3,4-methylen... |
Behavioural Pharmaco... |
1992 |
| Michel RE, Rege AB, Georg... |
High-pressure liquid chromatography/electrochemical detection method f... |
J Neurosci Methods |
1993 |
| Poklis A, Fitzgerald RL, ... |
EMIT-d.a.u. monoclonal amphetamine/methamphetamine assay. II. Detectio... |
Forensic Sci Int |
1993 |
| Cadet JL, Ladenheim B, Ba... |
CuZn-superoxide dismutase (CuZnSOD) transgenic mice show resistance to... |
Brain Res |
1994 |
| Nash JF, Roth BL, Brodkin... |
Effect of the R(-) and S(+) isomers of MDA and MDMA on phosphatidyl in... |
Neurosci Lett |
1994 |
| Colado MI, Williams JL, G... |
The hyperthermic and neurotoxic effects of 'Ecstasy' (MDMA) and 3,4 me... |
Br J Pharmacol |
1995 |
| Hegadoren KM, Baker GB, C... |
Analysis of the enantiomers of 3,4-methylenedioxy-N-ethylamphetamine (... |
J Pharmacol Toxicol ... |
1995 |
| Bronson ME, Jiang W, DeRu... |
A behavioral comparison of Nexus, cathinone, BDB, and MDA |
Pharmacol Biochem Be... |
1995 |
| Moore KA, Mozayani A, Fie... |
Distribution of 3,4-methylenedioxymethamphetamine (MDMA) and 3,4-methy... |
Forensic Sci Int |
1996 |
| Bronson ME, Wages TD, Bed... |
Morphine, MDMA, MDA, and nexus produce a conditioned place preference ... |
Exp Clin Psychopharm... |
1996 |
| Tucker G |
Adam and Eve make love. Analysis of the enantiomers of 3,4-methylenedi... |
Hum Exp Toxicol |
1996 |
| Kunsman GW, Levine B, Kuh... |
MDA-MDMA concentrations in urine specimens |
J Anal Toxicol |
1996 |
| Baker LE, Taylor MM |
Assessment of the MDA and MDMA optical isomers in a stimulant-hallucin... |
Pharmacol Biochem Be... |
1997 |
| Dal Cason TA, Meyers JA, ... |
Erratum to ‘Proton and Carbon-13 NMR assignments of 3,4-methylenedioxy... |
Forensic Sci Int |
1997 |
| Colado MI, Granados R, O'... |
Role of hyperthermia in the protective action of clomethiazole against... |
Br J Pharmacol |
1998 |
| Farber NB, Hanslick J, Ki... |
Serotonergic agents that activate 5HT2A receptors prevent NMDA antagon... |
Neuropsychopharmacol... |
1998 |
| Parker MA, Marona-Lewicka... |
Synthesis and pharmacological evaluation of ring-methylated derivative... |
J Med Chem |
1998 |
| Hensley D, Cody JT |
Simultaneous determination of amphetamine, methamphetamine, methylened... |
J Anal Toxicol |
1999 |
| Arvanov VL, Liang X, Russ... |
LSD and DOB: interaction with 5-HT2A receptors to inhibit NMDA recepto... |
Eur J Neurosci |
1999 |
| Jurado C, Gimenez MP, et ... |
Rapid analysis of amphetamine, methamphetamine, MDA, and MDMA in urine... |
J Anal Toxicol |
2000 |
| Russell BR, Laverty R |
Correlation between 5-HT content and uptake site density following (S)... |
Ann N Y Acad Sci |
2000 |
| Pentney AR |
An exploration of the history and controversies surrounding MDMA and M... |
J Psychoactive Drugs |
2001 |
| Clauwaert KM, Van Bocxlae... |
Stability study of the designer drugs 'MDA, MDMA and MDEA' in water, s... |
Forensic Sci Int |
2001 |
| Krupitsky EM, Burakov AM,... |
Attenuation of ketamine effects by nimodipine pretreatment in recoveri... |
Neuropsychopharmacol... |
2001 |
| Gandolfi O, Gaggi R, Volt... |
The activation of serotonin receptors prevents glutamate-induced neuro... |
Pharmacol Res |
2002 |
| Nordgren HK, Beck O |
Direct screening of urine for MDMA and MDA by liquid chromatography-ta... |
J Anal Toxicol |
2003 |
| De Letter EA, Espeel MF, ... |
Immunohistochemical demonstration of the amphetamine derivatives 3,4-m... |
Int J Legal Med |
2003 |
| Stout PR, Klette KL, Wieg... |
Comparison and evaluation of DRI methamphetamine, DRI ecstasy, Abuscre... |
J Anal Toxicol |
2003 |
| Huang Z, Zhang S |
Confirmation of amphetamine, methamphetamine, MDA and MDMA in urine sa... |
J Chromatogr B Analy... |
2003 |
| Schifano F, Oyefeso A, Co... |
Death rates from ecstasy (MDMA, MDA) and polydrug use in England and W... |
Hum Psychopharmacol |
2003 |
| Easton N, Fry J, O'Shea E... |
Synthesis, in vitro formation, and behavioural effects of glutathione ... |
Brain Res |
2003 |
| Moyano S, Frechilla D, De... |
NMDA receptor subunit and CaMKII changes in rat hippocampus induced by... |
Psychopharmacology (... |
2004 |
| Schifano F |
A bitter pill. Overview of ecstasy (MDMA, MDA) related fatalities |
Psychopharmacology (... |
2004 |
| da Costa JL, da Matta Cha... |
Determination of MDMA, MDEA and MDA in urine by high performance liqui... |
J Chromatogr B Analy... |
2004 |
| Concheiro M, de Castro A,... |
Determination of MDMA, MDA, MDEA and MBDB in oral fluid using high per... |
Forensic Sci Int |
2005 |
| Elliott SP |
MDMA and MDA concentrations in antemortem and postmortem specimens in ... |
J Anal Toxicol |
2005 |
| Lambe EK, Aghajanian GK |
Hallucinogen-Induced UP States in the Brain Slice of Rat Prefrontal Co... |
Neuropsychopharmacol... |
2005 |
| Bexis S, Docherty JR |
Effects of MDMA, MDA and MDEA on blood pressure, heart rate, locomotor... |
Br J Pharmacol |
2006 |
| Drees JC, Stone JA, Wu AH |
Morbidity involving the hallucinogenic designer amines MDA and 2C-I |
J Forensic Sci |
2009 |
| Baggott MJ, Siegrist JD, ... |
Investigating the Mechanisms of Hallucinogen-Induced Visions Using 3,4... |
Plos One |
2010 |
| Reissig CJ, Carter LP, Jo... |
High doses of dextromethorphan, an NMDA antagonist, produce effects si... |
Psychopharmacology (... |
2012 |
| Dal Cason TA, Corbett CA,... |
An unusual clandestine laboratory synthesis of 3,4-methylenedioxyamphe... |
Forensic Sci Int |
2012 |
| Sanacora G, Smith MA, Pat... |
Lanicemine: a low-trapping NMDA channel blocker produces sustained ant... |
Mol Psychiatry |
2013 |
| Zorumski CF, Nagele P, Me... |
Treatment-Resistant Major Depression: Rationale for NMDA Receptors as ... |
Front Psychiatry |
2015 |
| Pálenícek T, Lhotková E, ... |
Emerging toxicity of 5,6-methylenedioxy-2-aminoindane (MDAI): Pharmaco... |
Prog Neuropsychophar... |
2016 |
| Kang H, Park P, Bortolott... |
Ephenidine: A new psychoactive agent with ketamine-like NMDA receptor ... |
Neuropharmacology |
2017 |
| Ingram R, Kang H, Lightma... |
Some distorted thoughts about ketamine as a psychedelic and a novel hy... |
Neuropharmacology |
2018 |
